10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)

Q: What does CUSIP 88025U109 represent in this 13F holders report?

CUSIP 88025U109 is the security identifier for TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share in Q4 2020?

299 institutional investors reported TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share for Q4 2020. Use the holders table for investor-level position and value details.

CUSIP: 88025U109

Q4 2020 13F Holders as of 31 Dec 2020

Security type / class: Equity / Class A Common Stock, $0.00001 par value per share
Total 13F shares: 66,229,914
Total 13F value: $9,377,686,882
Share change: -5,616,985
Put/Call ratio: 30%
SEC-reported price per share: $141.60
Number of holders: 299
Value change: -$749,751,524
Number of buys: 208
Number of sells: 93
Shares outstanding: 116,858,154

Security key

88025U109

Report period

Q4 2020

Institutions

299

Top holders

TXG full security history Ownership snapshot Full 13F holder table 10x Genomics, Inc. SEC filings 10x Genomics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

15/15

Latest evidence

30 Sep 2020

13F Lead comparable stake: 8.3% Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 8.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 5

MORGAN STANLEY 8.3%

FMR LLC 7.3%

Venrock Management VI, LLC 7%

VANGUARD GROUP INC 5.1%

Foresite Capital Management II, LLC 3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	8.3%	$1,210,211,000 9,706,543 shares	—	30 Sep 2020
FMR LLC	13F Company 13F	7.3%	$1,070,589,000 8,586,694 shares	—	30 Sep 2020
Venrock Management VI, LLC	13F Company 13F	7%	$952,538,000 8,185,565 shares	—	30 Sep 2020
VANGUARD GROUP INC	13F Company 13F	5.1%	$742,397,000 5,954,418 shares	—	30 Sep 2020
Foresite Capital Management II, LLC	13F Company 13F	3%	$436,820,000 3,503,528 shares	—	30 Sep 2020
BlackRock Finance, Inc.	13F Company 13F	2.8%	$410,012,000 3,288,510 shares	—	30 Sep 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

299

66,229,914

Rows available

299

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders

215

Q4 2020 holders

299

Holder diff

Investor	Q3 2020 Shares	Q4 2020 Shares	Share Diff	Share Chg %	Q3 2020 value	Q4 2020 value	Value change	Value Chg %